Gilenya (fingolimod) - Risk Of Liver Injury

Gilenya (fingolimod) Recall Summary Gilenya, a prescription medication, is being recalled across Canada due to a risk of liver injury. The drug is used to treat multiple sclerosis and is distributed to patients nationwide. Anyone currently taking this medication is potentially affected by this recall.

Reason

Product safety

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2021-01-18

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/6a6f8874-522a-448d-96d5-ef5d5e60d854